Miwa H, Orita K
Acta Med Okayama. 1978 Oct;32(5):363-7.
Ninety-nine gastric cancer patients initially received levamisole at a daily dose of 150 mg for three consecutive days before operation. This therapy was repeated fortnightly (3-day administration followed by 11-day withdrawal period) for more than one month as long as possible and the survival rate up to 18 months was compared with thas of control patients. The 18 month survival rate of advanced Stage IV patients was significantly higher in patients receiving levamisole than that of control patients. The effects of levamisole in cases of advanced cancer have been discussed in relation to the literature available.
99例胃癌患者在术前连续3天每天接受150毫克左旋咪唑治疗。只要可能，这种治疗每两周重复一次（给药3天，随后停药11天），持续一个多月，并将18个月的生存率与对照组患者进行比较。接受左旋咪唑治疗的晚期IV期患者的18个月生存率显著高于对照组患者。已结合现有文献讨论了左旋咪唑在晚期癌症病例中的作用。
